Bristol-Myers Squibb to Hold Investor Webcast to Discuss ESMO Highlights

NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will host a webcast on Saturday, September 28, 2019 at 7:30 p.m. CEST (1:30 p.m. EDT) to discuss data presented at the European Society of Medical Oncology, in Barcelona, Spain. Company executives will provide an overview of data presented at the meeting, with a focus on the company’s Immuno-Oncology portfolio, and address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast at: investor.bms.com and are urged to register prior to the webcast. Materials related to the call will be available at the same website prior to the call.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190920005033/en/

Media:
Carrie Fernandez, 609-252-5222, [email protected]

Investors:
Tim Power, 609-252-7509, [email protected]

Source: Bristol-Myers Squibb Company

You May Also Be Interested In

• AM Best Affirms Credit Ratings of OneNexus Oklahoma Captive Corp.
• Luma Hydrogen Launches with 400 km² Geologic Hydrogen Land Position in Atlantic Canada and Commences Summer 2026 Exploration Program
• Helcim Raises $53 Million Series C as Banks Exit Small Business Payments